Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Human immunodeficiency virus 1 | Aberrant vpr protein | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | conserved hypothetical protein | 0.0089 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0089 | 0 | 0.5 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0089 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0089 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0089 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0089 | 0 | 0.5 |
Giardia lamblia | NADPH oxidoreductase, putative | 0.0089 | 0 | 0.5 |
Giardia lamblia | NADPH oxidoreductase, putative | 0.0089 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0177 | 0.7586 | 0.2349 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0089 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0089 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0089 | 0 | 0.5 |
Schistosoma mansoni | calcium-activated potassium channel | 0.0177 | 0.7586 | 0.2349 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0089 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0177 | 0.7586 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0089 | 0 | 0.5 |
Echinococcus multilocularis | geminin | 0.0205 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0089 | 0 | 0.5 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0089 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0089 | 0 | 0.5 |
Trichomonas vaginalis | NAD(P)H dehydrogenase, putative | 0.0089 | 0 | 0.5 |
Giardia lamblia | NADPH oxidoreductase, putative | 0.0089 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0089 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.7943 uM | PubChem BioAssay. qHTS Assay for Inhibitors of the HIV-1 protein Vpr. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 1.8526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 13.1154 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 14.581 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.